Aerosolized bexarotene inhibits lung tumorigenesis without increasing plasma triglyceride and cholesterol levels in mice

Cancer Prevention Research

Volumn 4, Issue 2, 2011, Pages 270-276

  Zhang, Qi ^a   Pan, Jing ^a   Zhang, Jingjie ^b   Liu, Pengyuan ^a   Chen, Ruth ^b   Chen, Da Ren ^b   Lubet, Ronald ^c   Wang, Yian ^a   You, Ming ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; BEXAROTENE; TRIOCTANOIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; IN VIVO STUDY; LUNG CANCER; LUNG TUMOR; MEDICAL RECORD; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, INHALATION; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CHOLESTEROL; FEMALE; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MICE; MICE, INBRED A; TETRAHYDRONAPHTHALENES; TRIGLYCERIDES;

EID: 79551709612     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0246     Document Type: Article

References (27)

1. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:1672-94.
2. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985;45:1-8. (Pubitemid 15196921)
3. William WN Jr, Heymach JV, Kim ES, Lippman SM. Molecular targets for cancer chemoprevention. Nat Rev Drug Discov 2009;8:213-25.
4. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54. (Pubitemid 34160518)
5. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 2008;10:475-510.
6. Wang Y, Zhang Z, Yao R, Jia D, Wang D, Lubet RA, et al. Prevention of lung cancer progression by bexarotene in mouse models. Oncogene 2006;25:1320-9. (Pubitemid 43336460)
7. Lubet RA, Szabo E, Christov K, Bode AM, Ericson ME, Steele VE, et al. Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes. Mol Cancer Ther 2008;7:972-9. (Pubitemid 351551051)
8. de Vries-van der Weij J, de Haan W, Hu L, Kuif M, Oei HL, van der Hoorn JW, et al. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein. Endocrinology 2009;150:2368-75.
9. Farol LT, Hymes KB. Bexarotene: a clinical review. Expert Rev Anticancer Ther 2004;4:180-8. (Pubitemid 38477332)
10. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003;56:588-99. (Pubitemid 37491710)
11. Yan Y, Cook J, McQuillan J, Zhang G, Hitzman CJ, Wang Y, et al. Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice. Neoplasia 2007;9:401-5. (Pubitemid 46799983)
12. Guyton AC. Measurement of the respiratory volumes of laboratory animals. Am J Physiol 1947;150:70-7.
13. Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff GJ, Anderson MW, et al. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res 2000;60:901-7. (Pubitemid 30129524)
14. Wang Y, Zhang Z, Kastens E, Lubet RA, You M. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Cancer Res 2003;63:4389-95. (Pubitemid 36951008)
15. Zhang Q, Fu H, Pan J, He J, Ryota S, Hara Y, et al. Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice. Pharm Res 2010;27:1066-71.
16. Gottardis MM, Bischoff ED, Shirley MA, Wagoner MA, Lamph WW, Heyman RA. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand. Cancer Res 1996;56:5566-70. (Pubitemid 26422151)
17. Miller VA, Benedetti FM, Rigas JR, Verret AL, Pfister DG, Straus D, et al. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol 1997;15:790-5. (Pubitemid 27074250)
18. Dragnev KH, Petty WJ, Shah SJ, Lewis LD, Black CC, Memoli V, et al. A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer. Clin Cancer Res 2007;13:1794-800. (Pubitemid 46952948)
19. Rizvi NA, Marshall JL, Dahut W, Ness E, Truglia JA, Loewen G, et al. A phase I study of LGD1069 in adults with advanced cancer. Clin Cancer Res 1999;5:1658-64. (Pubitemid 29334442)
20. Musolino A, Panebianco M, Zendri E, Santini M, Di Nuzzo S, Ardizzoni A. Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega-3 fatty acids. Br J Haematol 2009;145:84-6.
21. Lowe MN, Plosker GL. Bexarotene. Am J Clin Dermatol 2000;1:245-50; discussion 51-2.
22. Pereira MA, Kramer PM, Nines R, Liu Y, Alyaqoub FS, Gunning WT, et al. Prevention of mouse lung tumors by targretin. Int J Cancer 2006;118:2359-62.
23. Wang Y, Wen W, Yi Y, Zhang Z, Lubet RA, You M. Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer. Cancer Prev Res 2009;2:1059-64.
24. Grubbs CJ, Lubet RA, Atigadda VR, Christov K, Deshpande AM, Tirmal V, et al. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers. Carcinogenesis 2006;27:1232-9. (Pubitemid 43985438)
25. Lalloyer F, Pedersen TA, Gross B, Lestavel S, Yous S, Vallez E, et al. Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver.Arterioscler Thromb Vasc Biol 2009;29:1488-95.
26. Wattenberg LW, Wiedmann TS, Estensen RD. Chemoprevention of cancer of the upper respiratory tract of the Syrian golden hamster by aerosol administration of difluoromethylornithine and 5-fluorouracil. Cancer Res 2004;64:2347-9. (Pubitemid 38523886)
27. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 1997;57:5489-92. (Pubitemid 28006753)